AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Crinetics Pharmaceuticals CEO Pizzuti Dana Sells Shares After Buying at Lower Price
ByAinvest
Thursday, Sep 4, 2025 5:08 pm ET1min read
Crinetics Pharmaceuticals, Inc. has recently disclosed that Dana Pizzuti, Chief Medical and Development Officer, has made a transaction involving the company's shares. Specifically, Pizzuti purchased 5,000 shares at a price of $16.89 per share on September 2, 2025, and subsequently sold an identical number of shares at $32.10 per share on the same day.
On September 2, 2025, Crinetics Pharmaceuticals, Inc. disclosed that Dana Pizzuti, Chief Medical and Development Officer, executed a significant transaction involving the company's shares. According to the SEC filing, Pizzuti purchased 5,000 shares at a price of $16.89 per share and subsequently sold an identical number of shares at $32.10 per share on the same day [1].The transaction was part of a pre-established Rule 10b5-1 trading plan adopted on May 21, 2025. This plan allows officers and directors to sell shares automatically without violating insider trading laws. The pre-set plan ensures that the transactions are executed at regular intervals, reducing the risk of market manipulation [2].
Following the transaction, Pizzuti's beneficial ownership of Crinetics Pharmaceuticals' shares increased to 96,270 shares, with 84,042 shares derived from vested and unvested stock options remaining outstanding [1].
The transaction is viewed as procedural and not a sudden disposition. It indicates that Pizzuti converted equity into cash through a documented and automated plan, rather than an ad hoc sale. This adherence to insider-trading controls and disclosure rules reflects compliance with Section 16 reporting and safe-harbor procedures [2].
For investors, this clarification underscores the routine nature of the transaction and the company's commitment to transparency and regulatory compliance.
References:
[1] https://www.tradingview.com/news/tradingview:aa13ae7bbadcc:0-crinetics-pharmaceuticals-officer-sells-shares/
[2] https://www.stocktitan.net/sec-filings/CRNX/form-4-crinetics-pharmaceuticals-inc-insider-trading-activity-76e8779e6612.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet